Therapies for non-alcoholic fatty liver disease: A 2022 update
Katie Shen, Achintya D. Singh, Jamak Modaresi Esfeh, Jamilé Wakim-Fleming
Abstract
The incidence of non-alcoholic fatty liver disease (NAFLD) is rapidly increasing and lifestyle interventions to treat this disease by addressing the underlying metabolic syndrome are often limited. Many pharmacological interventions are being studied to slow or even reverse NAFLD progression. This review for hepatologists aims to provide an updated understanding of the pathogenesis of NAFLD, current recommended therapies, and the most promising treatment options that are currently under development.
Topics & Concepts
MedicineFatty liverDiseaseMetabolic syndromeAlcoholic liver diseasePsychological interventionIntensive care medicinePathogenesisBioinformaticsInternal medicineObesityCirrhosisPsychiatryBiologyLiver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseAlcohol Consumption and Health Effects